Literature DB >> 17108142

An inherent role of integrin-linked kinase-estrogen receptor alpha interaction in cell migration.

Filippo Acconcia1, Bramanandam Manavathi, Joseph Mascarenhas, Amjad H Talukder, Gordon Mills, Rakesh Kumar.   

Abstract

Integrin-linked kinase (ILK) and estrogen receptor (ER)-alpha modulate cell migration. However, the crosstalk between ERalpha and ILK and the role of ILK in ERalpha-mediated cell migration remain unexplored. Here, we report that ILK participates in ERalpha signaling in breast cancer cells. We found that ILK binds ERalpha in vitro and in vivo through a LXXLL motif in ILK. Estrogen prevented ERalpha-ILK binding, resulting in phosphatidylinositol 3-kinase (PI3K)-dependent increase in ILK kinase activity. Furthermore, the regulation of ERalpha-ILK interaction was dependent on the PI3K pathway. Unexpectedly, transient knockdown or inhibition of ILK caused hyperphosphorylation of ERalpha Ser(118) in an extracellular signal-regulated kinase/mitogen-activated protein kinase pathway-dependent manner and an enhanced ERalpha recruitment to the target chromatin and gene expression, a process reversed by overexpression of ILK. Compatible with these interactions, estrogen regulated cell migration via the PI3K/ILK/AKT pathway with stable ILK overexpression hyperactivating cell migration. Thus, status of ILK signaling may be an important modifier of ER signaling in breast cancer cells and this pathway could be exploited for therapeutic intervention in breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108142     DOI: 10.1158/0008-5472.CAN-06-2676

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

Review 1.  Extranuclear signaling by estrogen: role in breast cancer progression and metastasis.

Authors:  V Cortez; M Mann; D W Brann; R K Vadlamudi
Journal:  Minerva Ginecol       Date:  2010-12

2.  Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells.

Authors:  Bin Shi; Jing Liang; Xiaohan Yang; Yan Wang; Youna Zhao; Huijian Wu; Luyang Sun; Ying Zhang; Yupeng Chen; Ruifang Li; Yu Zhang; Mei Hong; Yongfeng Shang
Journal:  Mol Cell Biol       Date:  2007-05-14       Impact factor: 4.272

3.  Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activity.

Authors:  Piergiorgio La Rosa; Valeria Pesiri; Guy Leclercq; Maria Marino; Filippo Acconcia
Journal:  Mol Endocrinol       Date:  2012-03-22

4.  Clathrin Heavy Chain Interacts With Estrogen Receptor α and Modulates 17β-Estradiol Signaling.

Authors:  Pierangela Totta; Valeria Pesiri; Masato Enari; Maria Marino; Filippo Acconcia
Journal:  Mol Endocrinol       Date:  2015-04-10

5.  ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance.

Authors:  Yichen Xu; Peiwei Huangyang; Ying Wang; Lingru Xue; Emily Devericks; Hao G Nguyen; Xiuyan Yu; Juan A Oses-Prieto; Alma L Burlingame; Sohit Miglani; Hani Goodarzi; Davide Ruggero
Journal:  Cell       Date:  2021-09-23       Impact factor: 66.850

Review 6.  Derailed estrogen signaling and breast cancer: an authentic couple.

Authors:  Bramanandam Manavathi; Oindrilla Dey; Vijay Narsihma Reddy Gajulapalli; Raghavendra Singh Bhatia; Suresh Bugide; Rakesh Kumar
Journal:  Endocr Rev       Date:  2012-09-04       Impact factor: 19.871

Review 7.  Integrin-linked kinase 1: role in hormonal cancer progression.

Authors:  Valerie Cortez; Binoj C Nair; Dimple Chakravarty; Ratna K Vadlamudi
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

8.  The Effects of 17β-estradiol in Cancer are Mediated by Estrogen Receptor Signaling at the Plasma Membrane.

Authors:  Filippo Acconcia; Maria Marino
Journal:  Front Physiol       Date:  2011-06-30       Impact factor: 4.566

9.  Androgen receptor in laryngeal carcinoma: could there be an androgen-refractory tumor?

Authors:  Anastasios K Goulioumis; John Varakis; Panos Goumas; Helen Papadaki
Journal:  ISRN Oncol       Date:  2011-11-29

10.  Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy.

Authors:  Zhuan Zhou; Joe X Qiao; Amit Shetty; George Wu; Yi Huang; Nancy E Davidson; Yong Wan
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.